Abstract
Cells respond to a wide range of cellular toxins by inducing a suicide pathway known as apoptosis. Apoptosis plays a critical role in development, tissue remodeling, and in the removal of damaged and genetically altered cells. Activation of cell death pathways must be tightly regulated as too much or too little apoptosis can have drastic consequences for tissue homeostasis and for disease initiation and progression. While the mechanism of how apoptosis is executed has been extensively studied, little is known about how other signaling pathways influence the decision to die. In this regard, members of the protein kinase C (PKC) family of serine/threonine protein kinases are emerging as important modulators of the apoptotic response. Here we will discuss the role of specific PKC isoforms in regulating cell death, and address how alterations in the expression or activity of some of these kinases contribute to human diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abeliovich, A., Chen, C., Goda, Y., Silva, A. J., Stevens, C. F., & Tonegawa, S. (1993a). Modified hippocampal long-term potentiation in PKC-gamma-mutant mice. Cell, 7, 1253–1262.
Abeliovich, A., Paylor, R., Chen, C., Kim, J. J., Wehner, J. M., & Tonegawa, S. (1993b). PKC-gamma mutant mice exhibit mild deficits in spatial and contextual learning. Cell, 75, 1263–1271.
Abrams, S. T., Lakum, T., Lin, K., Jones, G. M., Treweeke, A. T., Farahani, M., et al. (2007). B-cell receptor signaling in chronic lymphocytic leukemia cells is regulated by overexpressed active protein kinase C beta. Blood, 109, 1193–1201.
Abukhdeir, A. M., & Park, B. H. (2008). P21 and p27: Roles in carcinogenesis and drug resistance. Expert Reviews in Molecular Medicine, 10, e19.
Acs, P., Beheshti, M., Szallasi, Z., Li, L., Yuspa, S. H., & Blumberg, P. M. (2000). Effect of a tyrosine 155 to phenylalanine mutation of protein kinase C delta on the proliferative and tumorigenic properties of NIH 3T3 fibroblasts. Carcinogenesis, 21, 887–891.
Adams, J. M. (2003). Ways of dying: Multiple pathways to apoptosis. Genes and Development, 17, 2481–2495.
Ainsworth, P. D., Winstanley, J. H., Pearson, J. M., Bishop, H. M., & Garrod, D. R. (2004). Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinoma. European Journal of Cancer, 40, 2269–2273.
Akimoto, K., Mizuno, K., Osada, S., Hirai, S., Tanuma, S., Suzuki, K., et al. (1994). A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. The Journal of Biological Chemistry, 269, 12677–12683.
Alvaro, V., Levy, L., Dubray, C., Roche, A., Peillon, F., Querat, B., et al. (1993). Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C. Journal of Clinical Endocrinology and Metabolism, 77, 1125–1129.
Assender, J. W., Gee, J. M., Lewis, I., Ellis, I. O., Robertson, J. F., & Nicholson, R. I. (2007). Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer. Journal of Clinical Pathology, 60, 1216–1221.
Aziz, M. H., Manoharan, H. T., Church, D. R., Dreckschmidt, N. E., Zhong, W., Oberley, T. D., et al. (2007). Protein kinase C epsilon interacts with signal transducers and activators of transcription 3 (stat3), phosphorylates stat3ser727, and regulates its constitutive activation in prostate cancer. Cancer Research, 67, 8828–8838.
Barr, L. F., Campbell, S. E., & Baylin, S. B. (1997). Protein kinase C-beta 2 inhibits cycling and decreases c-myc-induced apoptosis in small cell lung cancer cells. Cell Growth and Differentiation, 8, 381–392.
Basu, A., Lu, D., Sun, B., Moor, A. N., Akkaraju, G. R., & Huang, J. (2002). Proteolytic activation of protein kinase C-epsilon by caspase-mediated processing and transduction of antiapoptotic signals. The Journal of Biological Chemistry, 277, 41850–41856.
Basu, A., & Sivaprasad, U. (2007). Protein kinase C epsilon makes the life and death decision. Cellular Signalling, 19, 1633–1642.
Berra, E., Diaz-Meco, M. T., Dominguez, I., Municio, M. M., Sanz, L., Lozano, J., et al. (1993). Protein kinase C zeta isoform is critical for mitogenic signal transduction. Cell, 74, 555–563.
Berra, E., Municio, M. M., Sanz, L., Frutos, S., Diaz-Meco, M. T., & Moscat, J. (1997). Positioning atypical protein kinase C isoforms in the uv-induced apoptotic signaling cascade. Molecular and Cellular Biology, 17, 4346–4354.
Besson, A., & Yong, V. W. (2000). Involvement of p21(waf1/cip1) in protein kinase C alpha-induced cell cycle progression. Molecular and Cellular Biology, 20, 4580–4590.
Bharti, A., Kraeft, S.-K., Gounder, M., Pandey, P., Jin, S., Yuan, Z.-M., et al. (1998). Inactivation of DNA-dependent protein kinase by protein kinase C delta: Implications for apoptosis. Molecular and Cellular Biology, 18, 6719–6728.
Black, J. D. (2000). Protein kinase C-mediated regulation of the cell cycle. Frontiers in Bioscience, 5, D406–D423.
Blagosklonny, M. V. (2002). Are p27 and p21 cytoplasmic oncoproteins? Cell Cycle, 1, 391–393.
Blass, M., Kronfeld, I., Kazimirsky, G., Blumberg, P., & Brodie, C. (2002). Tyrosine phosphorylation of protein kinase C delta is essential for its apoptotic effect in response to etoposide. Molecular and Cellular Biology, 22, 182–195.
Cacace, A. M., Ueffing, M., Han, E. K.-H., Marmè, D., & Weinstein, I. (1998). Overexpression of PKC epsilon in R6 fibroblasts causes increased production of active TGFbeta. Journal of Cellular Physiology, 175, 314–322.
Cacace, A. M., Ueffing, M., Philipp, A., Han, E. K.-H., Kolch, W., & Weinstein, I. B. (1996). PKC epsilon functions as an oncogene by enhancing activation of the raf kinase. Oncogene, 13, 2517–2626.
Cameron, A. J., Procyk, K. J., Leitges, M., & Parker, P. J. (2008). PKC alpha protein but not kinase activity is critical for glioma cell proliferation and survival. International Journal of Cancer, 123, 769–779.
Cartron, P.-F., Juin, P., Oliver, L., Martin, S., Meflah, K., & Vallette, F. M. (2003). Nonre‑dundant role of bax and bak in bid-mediated apoptosis. Molecular and Cellular Biology, 23, 4701–4712.
Cataldi, A., Di Pietro, R., Centurione, L., Rapino, M., Santavenere, E., Garaci, F., et al. (2003). Engagement of PI-3-kinase mediated protein kinase C zeta activation in protecting friend cells from ionizing radiation-induced apoptosis. International Journal of Oncology, 22, 129–135.
Catley, M. C., Cambridge, L. M., Nasuhara, Y., Ito, K., Chivers, J. E., Beaton, A., et al. (2004). Inhibitors of protein kinase C (PKC) prevent activated transcription: Role of events downstream of NF-κB DNA binding. The Journal of Biological Chemistry, 279, 18457–18466.
Charruyer, A., Jean, C., Colomba, A., Jaffrazou, J.-P., Quillet-Mary, A., Laurent, G., et al. (2007). PKC iota protects against uv-c-induced apoptosis by inhibiting acid sphingomyelinase-dependent ceramide production. Biochemical Journal, 405, 77–83.
Child, E. S., & Mann, D. J. (2006). The intricacies of p21 phosphorylation: Protein/protein interactions, subcellular localization and stability. Cell Cycle, 5, 1313–1319.
Chipuk, J., & Green, D. R. (2006). Dissecting p53-dependent apoptosis. Cell Death and Differentiation, 13, 994–1002.
Churchill, E., Budas, G., Vallentin, A., Koyanagi, T., & Mochly-Rosen, D. (2008). PKC isozymes in chronic cardiac disease: Possible therapeutic targets? Annual Review of Pharmacology and Toxicology, 48, 569–599.
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., et al. (2005). Mir-15 and mir-16 induce apoptosis by targeting bcl2. Proceedings of the National Academy of Science of the United States of America, 102, 13944–13949.
Clark, J. A., Black, A. R., Leontieva, O. V., Frey, M. R., Pysz, M. A., Kunneva, L., et al. (2004). Involvement of the ERK signaling cascade in protein kinase C-mediated cell cycle arrest in intestinal epithelial cells. The Journal of Biological Chemistry, 279, 9233–9247.
Coqueret, O. (2003). New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment? Trends in Cell Biology, 13, 65–70.
Cornford, P., Evans, J., Dodson, A., Parsons, K., Woolfenden, A., Neoptolemos, J., et al. (1999). Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. American Journal of Pathology, 154, 137–144.
Cory, S., Huang, D. C., & Adams, J. M. (2003). The bcl-2 family: Roles in cell survival and oncogenesis. Oncogene, 22, 8590–8607.
Crawford, A. M., Kerr, J. F., & Currie, A. R. (1972). The relationship of acute mesodermal cell death to the teratogenic effects of 7-OHM-12-MBA in the foetal rat. British Journal of Cancer, 26, 498–503.
D’Costa, A. M., & Denning, M. F. (2005). A caspase-resistant mutant of PKC-delta protects keratinocytes from uv-induced apoptosis. Cell Death and Differentiation, 12, 224–232.
D’Costa, A., Robinson, J., Maududi, T., Chaturvedi, V., Nickoloff, B. J., & Denning, M. F. (2006). The proapoptotic tumor suppressor protein kinase C-delta is lost in human squamous cell carcinomas. Oncogene, 25, 375–386.
Datta, K., Nambudripad, R., Pal, S., Zhou, M., Cohen, H. T., & Mukhopadhyay, D. (2000). Inhibition of insulin-like growth factor-1-mediated cell signaling by the von hippel-lindau gene product in renal cancer. The Journal of Biological Chemistry, 275, 20700–20706.
de Thonel, A., Bettaieb, A., Jean, C., Laurent, G., & Quillet-Mary, A. (2001). Role of protein kinase C zeta isoform in Fas resistance of immature myeloid KG1a leukemic cells. Blood, 98, 3770–3777.
Debatin, K. M., Poncet, D., & Kroemer, G. (2002). Chemotherapy: Targeting the mitochondrial cell death pathway. Oncogene, 21, 8786–8803.
Dempsey, E. C., Newton, A. C., Mochly-Rosen, D., Fields, A. P., Reyland, M. E., Insel, P. A., et al. (2000). Protein kinase C isozymes and the regulation of diverse cell responses. American Journal of Physiology, 279, L429–L438.
Deng, X., Ito, T., Carr, B., Mumby, M., & May, W. S., Jr. (1998). Reversible phosphorylation of bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2a. The Journal of Biological Chemistry, 273, 34157–34163.
Detjen, K., Brembeck, F., Welzel, M., Kaiser, A., Haller, H., Wiedenmann, B., et al. (2000). Activation of protein kinase C alpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest. Journal of Cell Science, 113, 3025–3035.
DeVries, T. A., Neville, M. C., & Reyland, M. E. (2002). Nuclear import of PKC delta is required for apoptosis: Identification of a novel nuclear import sequence. EMBO Journal, 21, 6050–6060.
DeVries-Seimon, T. A., Ohm, A. M., Humphries, M. J., & Reyland, M. E. (2007). Induction of apoptosis is driven by nuclear retention of protein kinase C delta. The Journal of Biological Chemistry, 282, 22307–22314.
Dhanasekaran, D., & Reddy, E. (2008). JNK signaling in apoptosis. Oncogene, 27, 6245–6251.
Diaz-Meco, M., Berra, E., Municio, M., Sanz, L., Lozano, J., Dominguez, I., et al. (1993). A dominant negative protein kinase Cζ subspecies blocks NF-κB activation. Molecular and Cellular Biology, 13, 4770–4775.
Diaz-Meco, M. T., Lallena, M. J., Monjas, A., Frutos, S., & Moscat, J. (1999). Inactivation of the inhibitory κB protein kinase/nuclear factor κB pathway by par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis. The Journal of Biological Chemistry, 274, 19606–19612.
Diaz-Meco, M. T., & Moscat, J. (2008). AKT regulation and lung cancer: A novel role and mechanism of action for the tumor suppressor par-4. Cell Cycle, 7, 2817–2820.
Diaz-Meco, M., Municio, M., Frutos, S., Sanchez, P., Lazano, J., Sanz, L., et al. (1996). The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell, 86, 777–786.
Ding, L., Wang, H., Lang, W., & Xiao, L. (2002). Protein kinase C-epsilon promotes survival of lung cancer cells by suppressing apoptosis through dysregulation of the mitochondrial caspase pathway. The Journal of Biological Chemistry, 277, 35305–35313.
Dooley, N. P., Baltuch, G. H., Groome, N., Villemure, J. G., & Yong, V. W. (1998). Apoptosis is induced in glioma cells by antisense oligonucleotides to protein kinase C alpha and is enhanced by cycloheximide. Neuroreport, 9, 1727–1733.
Doornbos, R. P., Theelen, M., van der Hoeven, P. C., van Blitterswijk, W. J., Verkleij, A. J., & van Bergen en Henegouwen, P. M. (1999). Protein kinase C zeta is a negative regulator of protein kinase B activity. The Journal of Biological Chemistry, 274, 8589–8596.
Eguchi, K. (2001). Apoptosis in autoimmune diseases. Internal Medicine, 40, 275–284.
Ekshyyan, O., & Aw, T. Y. (2004). Apoptosis: A key in neurodegenerative disorders. Current Neurovascular Research, 1, 355–371.
Ellis, H., & Horvitz, H. R. (1986). Genetic control of programmed cell death in the nematode c. Elegans. Cell, 44, 817–829.
El-Rayes, B. F., Ali, S., Philip, P. A., & Sarkar, F. H. (2008). Protein kinase C: A target for therapy in pancreatic cancer. Pancreas, 36, 346–352.
Emoto, Y., Kisaki, H., Manome, Y., Kharbanda, S., & Kufe, D. (1996). Activation of protein kinase C delta in human myeloid leukemia cells treated with 1-β-d-arabinofuranosylcytosine. Blood, 87, 1990–1996.
Engers, R., Mrzyk, S., Springer, E., Fabbro, D., Weissgerber, G., Gernharz, C. D., et al. (2000). Protein kinase C in human renal cell carcinomas: Role in invasion and differential isoenzyme expression. British Journal of Cancer, 82, 1063–1069.
Erster, S., Mihara, M., Kim, R. H., Petrenko, O., & Moll, U. M. (2004). In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Molecular and Cellular Biology, 24, 6728–6741.
Espinosa, I., Briones, J., Bordes, R., Brunet, S., Martino, R., Sureda, A., et al. (2006). Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma. Annals of Hematology, 85, 597–603.
Evan, G., & Vousden, K. (2001). Proliferation, cell cycle and apoptosis in cancer. Nature, 411, 342–348.
Fan, C., Katsuyama, M., & Yabe-Nishimura, C. (2005). Protein kinase C delta mediates up-regulation of nox1, a catalytic subunit of nadph oxidase, via transactivation of the EGF receptor: Possible involvement of PKC delta in vascular hypertrophy. Biochemical Journal, 390, 761–767.
Fields, A. P., Frederick, L. A., & Regala, R. P. (2007). Targeting the oncogenic protein kinase C iota signaling pathway for the treatment of cancer. Biochemical Society Transactions, 35, 996–1000.
Fields, A. P., & Regala, R. P. (2007). Protein kinase C iota: Human oncogene, prognostic marker and therapeutic target. Pharmacological Research, 55, 487–497.
Filomenko, R., Poirson-Bichat, F., Billerey, C., Belon, J. P., Garrido, C., Solary, E., et al. (2002). Atypical protein kinase C zeta as a target for chemosensitization of tumor cells. Cancer Research, 62, 1815–1821.
Fournier, D. B., Chisamore, M., Lurain, J. R., Rademaker, A. W., Jordan, V. C., & Tonetti, D. A. (2001). Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: Possible role in AP-1-mediated proliferation of ER-negative endometrial cancer. Gynecologic Oncology, 81, 366–372.
Franke, T. (2007). PI3K/AKT:Getting it right matters. Oncogene, 27, 6473–6488.
Franz, M. G., Norman, J. G., Fabri, P. J., & Gower, W. R., Jr. (1996). Differentiation of pancreatic ductal carcinoma cells associated with selective expression of protein kinase C isoforms. Annals of Surgical Oncology, 3, 564–569.
Frey, M. R., Clark, J. A., Leontieva, O., Uronis, J. M., Black, A. R., & Black, J. D. (2000). Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium. Journal of Cell Biology, 151, 763–778.
Frey, M. R., Saxon, M. L., Zhao, X., Rollins, A., Evans, S. S., & Black, J. D. (1997). Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. The Journal of Biological Chemistry, 272, 9424–9435.
Frey, M. R., Clark, J. A., Bateman, N. W., Kazanietz, M. G., Black, A. R., & Black, J. D. (2004). Cell cycle- and protein kinase C-specific effects of resiniferatoxin and resiniferonol 9,13,14-ortho-phenylacetate in intestinal epithelial cells. Biochemical Pharmacology, 67, 1873–1886.
Fujii, T., Garcia-Bermejo, M. L., Bernabo, J. L., Caamano, J., Ohba, M., Kuroki, T., et al. (2000). Involvement of protein kinase C delta (PKCdelta ) in phorbol ester-induced apoptosis in lncap prostate cancer cells. Lack of proteolytic cleavage of PKC delta. The Journal of Biological Chemistry, 275, 7574–7582.
Fuster, J. J., Sanz-Gonzalez, S. M., Moll, U. M., & Andres, V. (2007). Classic and novel roles of p53: Prospects for anticancer therapy. Trends in Molecular Medicine, 13, 192–199.
Galvez, A. S., Duran, A., Linares, J. F., Pathrose, P., Castilla, E. A., Abu-Baker, S., et al. (2009). Protein kinase C zeta represses the interleukin-6 promoter and impairs tumorigenesis in vivo. Molecular and Cellular Biology, 29, 104–115.
Garin, G., Abe, J., Mohan, A., Lu, W., Yan, C., Newby, A. C., et al. (2007). Flow antagonizes TNF-alpha signaling in endothelial cells by inhibiting caspase-dependent PKC zeta processing. Circulation Research, 101, 97–105.
Gartsbein, M., Alt, A., Hashimoto, K., Nakajima, K., Kuroki, T., & Tennenbaum, T. (2006). The role of protein kinase C delta activation and STAT3 ser727 phosphorylation in insulin-induced keratinocyte proliferation. Journal of Cell Science, 119, 470–481.
Gavrielides, M. V., Frijhoff, A. F., Conti, C. J., & Kazanietz, M. G. (2004). Protein kinase C and prostate carcinogenesis: Targeting the cell cycle and apoptotic mechanisms. Current Drug Targets, 5, 431–443.
Gelinas, C., & White, E. (2005). BH3-only proteins in control: Specificity regulates mcl-1 and bak-mediated apoptosis. Genes and Development, 19, 1263–1268.
Ghayur, T., Hugunin, M., Talanian, R. V., Ratnofsky, S., Quinlan, C., Emoto, Y., et al. (1996). Proteolytic activation of protein kinase C delta by an ice/ced 3-like protease induces characteristics of apoptosis. Journal of Experimental Medicine, 184, 2399–2404.
Gilhooly, E. M., Morse-Gaudio, M., Bianchi, L., Reinhart, L., Rose, D. P., Connolly, J. M., et al. (2001). Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: A result of transformation or differentiation? Melanoma Research, 11, 355–369.
Gokmen-Polar, Y., Murray, N. R., Velasco, M. A., Gatalica, Z., & Fields, A. P. (2001). Elevated protein kinase C beta II is an early promotive event in colon carcinogenesis. Cancer Research, 61, 1375–1381.
Gomez-Angelats, M., & Cidlowski, J. A. (2001). Protein kinase C regulates Fadd recruitment and death-inducing signaling complex formation in Fas/cd95-induced apoptosis. The Journal of Biological Chemistry, 276, 44944–44952.
Gozuacik, D., & Kimchi, A. (2007). Autophagy and cell death. Current Topics in Developmental Biology, 78, 217–245.
Griner, E. M., & Kazanietz, M. G. (2007). Protein kinase C and other diacylglycerol effectors in cancer. Nature Reviews. Cancer, 7, 281–294.
Grossoni, V., Falbo, K., Kazanietz, M., de Kier Joffé, E., & Urtreger, A. (2007). Protein kinase C delta enhances proliferation and survival of murine mammary cells. Molecular Carcinogenesis, 46, 381–390.
Guan, L., Song, K., Pysz, M. A., Curry, K. J., Hizli, A. A., Danielpour, D., et al. (2007). Protein kinase C-mediated down-regulation of cyclin D1 involves activation of the translational repressor 4e-BP1 via a phosphoinositide 3-kinase/AKT-independent, protein phosphatase 2a-dependent mechanism in intestinal epithelial cells. The Journal of Biological Chemistry, 282, 14213–14225.
Guo, K., Li, Y., Kang, X., Sun, L., Cui, J., Gao, D., et al. (2009). Role of PKC beta in hepatocellular carcinoma cells migration and invasion in vitro: A potential therapeutic target. Clinical & Experimental Metastasis, 26, 189–195.
Gutcher, I., Webb, P. R., & Anderson, N. G. (2003). The isoform-specific regulation of apoptosis by protein kinase C. Cellular and Molecular Life Sciences, 60, 1061–1070.
Haimovitz-Friedman, A., Balaban, N., McLoughlin, M., Ehleiter, D., Michaeli, J., Vlodavsky, I., et al. (1994). Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Research, 54, 2591–2597.
Hanahan, D., & Weinberg, R. (2000). The hallmarks of cancer. Cell, 100, 57–70.
Harper, N., Hughes, M. A., Farrow, S. N., Cohen, G. M., & MacFarlane, M. (2003). Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing aigand-induced apoptosis by targeting the apical events of death receptor signaling. The Journal of Biological Chemistry, 278, 44338–44347.
Haughian, J. M., Jackson, T. A., Koterwas, D. M., & Bradford, A. P. (2006). Endometrial cancer cell survival and apoptosis is regulated by protein kinase C alpha and delta. Endocrine Related Cancer, 13, 1251–1267.
Hayashi, T., & Faustman, D. L. (2003). Role of defective apoptosis in type 1 diabetes and other autoimmune diseases. Recent Progress in Hormone Research, 58, 131–153.
Helton, S., & Chen, X. (2007). P53 modulation of the DNA damage response. Journal of Cellular Biochemistry, 100, 883–896.
Herrant, M., Liuciano, F., Loubat, A., & Auberger, P. (2002). The protective effect of phorbol esters on Fas-mediated apoptosis in T cells. Transcriptional and postranscriptional regulation. Oncogene, 21, 4957–4968.
Hizli, A. A., Black, A. R., Pysz, M. A., & Black, J. D. (2006). Protein kinase C alpha signaling inhibits cyclin D1 translation in intestinal epithelial cells. The Journal of Biological Chemistry, 281, 14596–14603.
Horvitz, H. R. (2003). Nobel lecture. Worms, life and death. Bioscience Reports, 23, 239–303.
Huang, D. C., & Strasser, A. (2000). BH3-only proteins-essential initiators of apoptotic cell death. Cell, 103, 839–842.
Humphries, M. J., Limesand, K. H., Schneider, J. C., Nakayama, K. I., Anderson, S. M., & Reyland, M. E. (2006). Suppression of apoptosis in the protein kinase C delta null mouse in vivo. The Journal of Biological Chemistry, 281, 9728–9737.
Humphries, M. J., Ohm, A. M., Schaack, J., Adwan, T. S., & Reyland, M. E. (2008). Tyrosine phosphorylation regulates nuclear translocation of PKC delta. Oncogene, 27, 3045–3053.
Ionov, Y., Yamamoto, H., Krajewski, S., Reed, J. C. & Perucho, M. (2000). Mutational inactivation of the proapoptotic gene bax confers selective advantage during tumor clonal evolution. Proceedings of the National Academy of Science of the United States of America, 97, 10872–10877.
Ito, Y., Mishra, N., Yoshida, K., Kharbanda, S., Saxena, S., & Kufe, D. (2001). Mitochondrial targeting of JNK/SAPK in the phorbol ester response of myeloid leukemia cells. Oncogene, 8, 794–800.
Jackson, D. N., & Foster, D. A. (2004). The enigmatic protein kinase C delta: Complex roles in cell proliferation and survival. FASEB Journal, 18, 627–636.
Jamieson, L., Carpenter, L., Biden, T. J., & Fields, A. P. (1999). Protein kinase C iota activity is necessary for bcr-abl-mediated resistance to drug-induced apoptosis. The Journal of Biological Chemistry, 274, 3927–3930.
Jansen, A. P., Verwiebe, E. G., Dreckschmidt, N. E., Wheeler, D. L., Oberley, T. D., & Verma, A. K. (2001). Protein kinase C-epsilon transgenic mice: A unique model for metastatic squamous cell carcinoma. Cancer Research, 61, 808–812.
Jiang, X. H., Tu, S. P., Cui, J. T., Lin, M. C., Xia, H. H., Wong, W. M., et al. (2004). Antisense targeting protein kinase C alpha and beta1 inhibits gastric carcinogenesis. Cancer Research, 64, 5787–5794.
Jiffar, T., Kurinna, S., Suck, G., Carlson-Bremer, D., Ricciardi, M. R., Konopleva, M., et al. (2004). PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on bcl2 phosphorylation. Leukemia, 18, 505–512.
Johnson, C. L., Lu, D., Huang, J., & Basu, A. (2002). Regulation of p53 stabilization by DNA damage and protein kinase C. Molecular Cancer Therapeutics, 1, 861–867.
Johnstone, R., Ruefli, A., & Lowe, S. (2002). Apoptosis: A link between cancer genetics and chemotherapy. Cell, 108, 135–144.
Jorgensen, K., Skrede, M., Cruciani, V., Mikalsen, S. O., Slipicevic, A., & Florenes, V. A. (2005). Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2. Biochemical and Biophysical Research Communications, 329, 266–274.
Joshi, J., Fernandez-Marcos, P. J., Galvez, A., Amanchy, R., Linares, J. F., Duran, A., et al. (2008). Par-4 inhibits AKT and suppresses ras-induced lung tumorigenesis. EMBO Journal, 27, 2181–2193.
Kahl-Rainer, P., Karner-Hanusch, J., Weiss, W., & Marian, B. (1994). Five of six protein kinase C isoenzymes present in normal mucosa show reduced protein levels during tumor development in the human colon. Carcinogenesis, 15, 779–782.
Kamimura, K., Hojo, H., & Abe, M. (2004). Characterization of expression of protein kinase C isozymes in human b-cell lymphoma: Relationship between its expression and prognosis. Pathology International, 54, 224–230.
Kerfoot, C., Huang, W., & Rotenberg, S. A. (2004). Immunohistochemical analysis of advanced human breast carcinomas reveals downregulation of protein kinase C alpha. Journal of Histochemistry and Cytochemistry, 52, 419–422.
Kerr, J. F. R. (1971). Shrinkage necrosis: A distinct mode of cellular death. Journal Pathology, 105, 13–20.
Kerr, J. F. R. (2002). History of the events leading to the formulation of the apoptosis concept. Toxicology, 181, 471–474.
Kerr, J. F. R., & Searle, J. (1972). Digestion of cellular fragments within the phagolysosoes in carcinoma cells. Journal of Pathology, 108, 55–58.
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer, 26, 239–257.
Keshamouni, V. G., Mattingly, R. R., & Reddy, K. B. (2002). Mechanism of 17-beta-estradiol-induced ERK1/2 activation in breast cancer cells. The Journal of Biological Chemistry, 277, 22558–22565.
Kharbanda, S., Pandey, P., Jin, S., Inoue, S., Bharti, A., Yuan, Z.-M., et al. (1997). Functional interaction between DNA-PK and c-abl in response to DNA damage. Nature, 386, 732–735.
Kiley, S. C., Clark, K. J., Duddy, S., Welch, D., & Jaken, S. (1999). Increased protein kinase C delta in mammary tumor cells: Relationship to transformation and metastatic progression. Oncogene, 18, 6748–6757.
Kiley, S. C., Clark, K. J., Goodnough, M., Welch, D. R., & Jaken, S. (1999). Protein kinase C delta involvement in mammary tumor cell metastasis. Cancer Research, 59, 3230–3238.
Kilpatrick, L. E., Lee, J. Y., Haines, K. M., Campbell, D. E., Sullivan, K. E., & Korchak, H. M. (2002). A role for PKC-delta and PI 3-kinase in TNF-alpha-mediated antiapoptotic signaling in the human neutrophil. American Journal of Physiology. Cell Physiology, 283, C48–C57.
Kim, G.-Y., Mercer, S. E., Ewton, D. Z., Yan, Z., Jin, K., & Friedman, E. (2002). The stress-activated protein kinases p38alpha and JNK1 stabilize p21cip1 by phosphorylation. The Journal of Biological Chemistry, 277, 29792–29802.
Knauf, J. A., Elisei, R., Mochly-Rosen, D., Liron, T., Chen, X.-N., Gonsky, R., et al. (1999). Involvement of protein kinase C epsilon in thyroid cell death. A truncated chimeric PKC epsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis. The Journal of Biological Chemistry, 274, 23414–23425.
Koivunen, J., Aaltonen, V., Koskela, S., Lehenkari, P., Laato, M., & Peltonen, J. (2004). Protein kinase C alpha/beta inhibitor GO6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells. Cancer Research, 64, 5693–5701.
Koivunen, J., Aaltonen, V., & Peltonen, J. (2006). Protein kinase C (PKC) family in cancer progression. Cancer Letters, 235, 1–10.
Kolch, W., Heidecker, G., Kochs, G., Hummel, R., Vahidi, H., Mischak, H., et al. (1993). Protein kinase C alpha activates raf-1 by direct phosphorylation. Nature, 364, 249–252.
Konishi, H., Tanaka, M., Takemura, Y., Hiderori, H., Ono, Y., Kikkawa, U., et al. (1997). Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proceedings of the National Academy of Science of the United States of America, 94, 11233–11237.
Konstantinidou, A., Korkolopoulou, P., & Patsouris, E. (2002). Apoptotic markers for tumor recurrence:A minireview. Apoptosis, 7, 461–470.
Koren, R., Ben Meir, D., Langzam, L., Dekel, Y., Konichezky, M., Baniel, J., et al. (2004). Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate. Oncology Reports, 11, 321–326.
Koren, R., Langzam, L., Paz, A., Livne, P. M., Gal, R., & Sampson, S. R. (2000). Protein kinase C (PKC) isoenzymes immunohistochemistry in lymph node revealing solution-fixed, paraffin-embedded bladder tumors. Applied Immunohistochemistry & Molecular Morphology, 8, 166–171.
Koriyama, H., Kouchi, Z., Umeda, T., Saido, T. C., Momoi, T., Ishiura, S., et al. (1999). Proteolytic activation of protein kinase C delta and epsilon by caspase-3 in U937 cells during chemotherapeutic agent-induced apoptosis. Cellular Signalling, 11, 831–838.
Krasagakis, K., Lindschau, C., Fimmel, S., Eberle, J., Quass, P., Haller, H., et al. (2004). Proliferation of human melanoma cells is under tight control of protein kinase C alpha. Journal of Cellular Physiology, 199, 381–387.
Kroemer, G. (1997). The proto-oncogene bcl-2 and its role in regulating apoptosis. Nature Medicine, 3, 614–620.
Kuwana, T., & Newmeyer, D. D. (2003). Bcl-2-family proteins and the role of mitochondria in apoptosis. Current Opinion in Cell Biology, 15, 691–699.
Lahn, M., Kohler, G., Sundell, K., Su, C., Li, S., Paterson, B. M., et al, (2004). Protein kinase C alpha expression in breast and ovarian cancer. Oncology, 67, 1–10.
Langzam, L., Koren, R., Gal, R., Kugel, V., Paz, A., Farkas, A., et al. (2001). Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy. American Journal of Clinical Pathology, 116, 377–385.
Laudanna, C., Sorio, C., Tecchio, C., Butcher, E. C., Bonora, A., Bassi, C., et al. (2003). Motility analysis of pancreatic adenocarcinoma cells reveals a role for the atypical zeta isoform of protein kinase C in cancer cell movement. Laboratory Investigation, 83, 1155–1163.
Le, X. F., Marcelli, M., McWatters, A., Nan, B., Mills, G. B., O’Brian, C. A., et al. (2001). Heregulin-induced apoptosis is mediated by down-regulation of bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity. Oncogene, 20, 8258–8269.
Lee, S., & Pervaiz, S. (2007). Apoptosis in the pathophysiology of diabetes mellitus. International Journal of Biochemistry and Cell Biology, 39, 497–504.
Leitges, M., Gimborn, K., Elis, W., Kalesnikoff, J., Hughes, M. R., Krystal, G., et al. (2002). Protein kinase C-delta is a negative regulator of antigen-induced mast cell degranulation. Molecular and Cellular Biology, 22, 3970–3980.
Leitges, M., Mayr, M., Braun, U., Mayr, U., Li, C., Pfister, G., et al. (2001). Exacerbated vein graft arteriosclerosis in protein kinase C delta-null mice. Journal of Clinical Investigation, 108, 1505–1512.
Leitges, M., Sanz, L., Martin, P., Duran, A., Braun, U., Garcia, J. F., et al. (2001). Targeted disruption of the zeta PKC gene results in the impairment of the NF-κB pathway. Molecular Cell, 8, 771–780.
Leroy, I., de Thonel, A., Laurent, G., & Quillet-Mary, A. (2005). Protein kinase C zeta associates with death inducing signaling complex and regulates fas ligand-induced apoptosis. Cellular Signalling, 17, 1149–1157.
Levine, B., Sinha, S., & Kroemer, G. (2008). Bcl-2 family members: Dual regulators of apoptosis and autophagy. Autophagy, 4, 600–606.
Li, W., Jiang, Y.-X., Zhang, J., Soon, L., Flechner, L., Kapoor, V., et al. (1998). Protein kinase C-delta is an important signaling molecule in insulin-like growth factor 1 receptor-mediated cell transformation. Molecular and Cellular Biology, 18, 5888–5898.
Li, L., Sampat, K., Hu, N., Zakari, J., & Yuspa, S. H. (2006). Protein kinase C negatively regulates AKT activity and modifies uvc-induced apoptosis in mouse keratinocytes. The Journal of Biological Chemistry, 281, 3237–3243.
Li, H., & Weinstein, I. B. (2006). Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells. Cancer Research, 66, 11399–11408.
Li, J., & Yuan, J. (2008). Caspases in apoptosis and beyond. Oncogene, 27, 6194–6206.
Li, W., Jiang, Y.-X., Zhang, J., Soon, L., Flechner, L., Kapoor, V., et al. (1998). Protein kinase C-delta is an important signaling molecule in insulin-like growth factor receptor-mediated cell transformation. Molecular and Cellular Biology, 18, 5888–5898.
Liadis, N., Murakami, K., Eweida, M., Elford, A. R., Sheu, L., Gaisano, H. Y., et al. (2005). Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus. Molecular and Cellular Biology, 25, 3620–3629.
Liao, L., Ramsay, K., & Jaken, S. (1994). Protein kinase C isozymes in progressively transformed rat embryo fibroblasts. Cell Growth and Differentiation, 5, 1185–1194.
Lin, D., & Takemoto, D., J. (2005). Oxidative activation of protein kianse C gamma through the c1 domain. Effects on gap junctions. The Journal of Biological Chemistry, 280, 13682–13693.
Lin, D., Shanks, D., Prakash, O., & Takemoto, D. J. (2007). Protein kinase C gamma mutations in the c1b domain cause caspase-3-linked apoptosis in lens epithelial cells through gap junctions. Experimental Eye Research, 85, 113–122.
Liu, H., Zhang, H. Y., Zhu, X., Shao, Z., & Yao, Z. (2002). Preconditioning blocks cardiocyte apoptosis: Role of K(ATP) channels and PKC-epsilon. American Journal of Physiology-Heart and Circulatory Physiology 282, H1380–H1386.
Liu, H., Lu, Z.-G., Miki, Y. & Yoshida, K. (2007). Protein kinase C delta induces transcription of the tp53 tumor suppressor gene by controlling death-promoting factor btf in the apoptotic response to DNA damage. Molecular and Cellular Biology, 27, 8480–8491.
Liu, Y., Su, W., Thompson, E. A., Leitges, M., Murray, N. R., & Fields, A. P. (2004). Protein kinase C betaII regulates its own expression in rat intestinal epithelial cells and the colonic epithelium in vivo. The Journal of Biological Chemistry, 279, 45556–45563.
Liu, Y., Wang, B., Wang, J., Wan, W., Sun, R., & Zhao, Y., et al. (2009). Down-regulation of pkczeta expression inhibits chemotaxis signal transduction in human lung cancer cells. Lung Cancer, 63, 210–218.
Lomonaco, S. L., Kahana, S., Blass, M., Brody, Y., Okhrimenko, H., Xiang, C., et al. (2008). Phosphorylation of protein kinase c{delta} on distinct tyrosine residues induces sustained activation of erk1/2 via down-regulation of mkp-1: Role in the apoptotic effect of etoposide. The Journal of Biological Chemistry, 283, 17731–17739.
Lu, Z., Hornia, A., Jiang, Y.-W., Zang, Q., Ohno, S. & Foster, D. (1997). Tumor promotion by depleting cells of protein kinase C delta. Molecular and Cellular Biology, 17, 3418–3428.
Ma, S., & Rosen, S. T. (2007). Enzastaurin. Current Opinion in Oncology, 19, 590–595.
Macfarlane, D., & Manzel, L. (1994). Activation of beta-isozyme of protein kinase C (pkc beta) is necessary and sufficient for phorbol ester-induced differentiation of hl-60 promyelocytes. Studies with pkc beta-defective pet mutant. The Journal of Biological Chemistry, 269, 4327–23484.
Mackay, H. J., & Twelves, C. J. (2003). Protein kinase C: A target for anticancer drugs? Endocrine-Related Cancer, 10, 389–396.
Majewski, M., Nieborowska-Skorska, M., Salomoni, P., Slupianek, A., Reiss, K., Trotta, R., et al. (1999). Activation of mitochondrial raf-1 is involved in the antiapoptotic effects of AKT. Cancer Research, 59, 2815–2819.
Majumder, P., Mishra, N., Sun, X., Bharti, A., Kharbanda, S., Saxena, S., et al. (2001). Targeting of protein kinase C delta to mitochondria in the oxidative stress response. Cell Death and Differentiation, 12, 465–470.
Majumder, P. K., Pandey, P., Sun, X., Cheng, K., Datta, R., Saxena, S., et al. (2000). Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis. The Journal of Biological Chemistry, 275, 21793–21796.
Mandil, R., Ashkenazi, E., Blass, M., Kronfeld, I., Kazimirsky, G., Rosenthal, G., et al. (2001). Protein kinase C alpha and protein kinase C delta play opposite roles in the proliferation and apoptosis of glioma cells. Cancer Research, 61, 4612–4619.
Mao, M., Fang, X., Lu, Y., Lapushin, R., Bast, R. C., Jr., & Mills, G. B. (2000). Inhibition of growth-factor-induced phosphorylation and activation of protein kinase b/akt by atypical protein kinase C in breast cancer cells. The Biochemistry Journal, 352 (Pt 2), 475–482.
Martiny-Baron, G., & Fabbro, D. (2007). Classical PKC isoforms in cancer. Pharmacological Research, 55, 477–486.
Masur, K., Lang, K., Niggemann, B., Zanker, K. S., & Entschladen, F. (2001). High pkc alpha and low e-cadherin expression contribute to high migratory activity of colon carcinoma cells. Molecular Biology of the Cell, 12, 1973–1982.
Matassa, A., Carpenter, L., Biden, T., Humphries, M. & Reyland, M. (2001). PKC delta is required for mitochondrial dependent apoptosis in salivary epithelial cells. The Journal of Biological Chemistry, 276, 29719–29728.
Matassa, A. A., Kalkofen, R. L., Carpenter, L., Biden, T. J., & Reyland, M. E. (2003). Inhibition of pkcalpha induces a pkcdelta-dependent apoptotic program in salivary epithelial cells. Cell Death and Differentiation, 10, 269–277.
Mayne, G. C. & Murray, A. W. (1998). Evidence that protein kinase cepsilon mediates phorbol ester inhibition of calphostin c- and tumor necrosis factor-α-induced apoptosis in u937 histiocytic lymphoma cells. The Journal of Biological Chemistry, 273, 24115–24121.
Mazzoni, E., Adam, A., Bal de Kier Joffe, E., & Aguirre-Ghiso, J. A. (2003). Immortalized mammary epithelial cells overexpressing protein kinase C gamma acquire a malignant phenotype and become tumorigenic in vivo. Molecular Cancer Research, 1, 776–787.
McJilton M. A., Wescott, G.G., Wu, D., Foreman, T. L., Gregory, C. W., Weidner, D. A., et al. (2003). Protein kinase C epsilon interacts with bax and promotes survival of human prostate cancer cells. Oncogene, 22, 7958–7968.
McKiernan, E., O’Brien, K., Grebenchtchikov, N., Geurts-Moespot, A., Sieuwerts, A., Martens, J., et al. (2008). Protein kinase C expression in breast cancer as measured by real-time PCR, western blotting and ELISA. British Journal of Cancer, 99, 1644–1650.
Mecklenbrauker, I., Kalled, S. L., Leitges, M., Mackay, F., & Tarakhovsky, A. (2004). Regulation of B-cell survival by baff-dependent PKC delta-mediated nuclear signaling. Nature, 431, 456–461.
Metzstein, M., Stanfield, G., & Horvitz, H. (1998). Genetics of programmed cell death in c. Elegans: Past, present and future. Trends in Genetics, 14, 410–416.
Mingo-Sion, A. M., Ferguson, H. A., Koller, E., Reyland, M. E., & Van Den Berg, C. L. (2005). PKC delta and mTOR interact to regulate stress and IGF-1 induced IRS-1 ser312 phosphorylation in breast cancer cells. Breast Cancer Research and Treatment, 91, 259–269.
Mischak, H., Goodnight, J. A., Kolch, W., Martiny-Baron, G., Schaechtle, C., Kazanietz, M. G., et al. (1993). Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. The Journal of Biological Chemistry, 268, 6090–6096.
Miyamoto, A., Nakayama, K., Imaki, H., Hirose, S., Jiang, Y., Abe, M., et al. (2002). Increased proliferation of B cells and auto-immunity in mice lacking protein kinase C delta. Nature, 416, 865–869.
Morse-Gaudio, M., Connolly, J. M., & Rose, D. P. (1998). Protein kinase C and its isoforms in human breast cancer cells: Relationship to the invasive phenotype. International Journal of Oncology, 12, 1349–1354.
Moscat, J., & Diaz-Meco, M. T. (2000). The atypical protein kinase C’s. Functional specificity mediated by specific protein adapters. EMBO Reports, 1, 399–403.
Murray, N. R., Davidson, L. A., Chapkin, R. S., Clay Gustafson, W., Schattenberg, D. G., & Fields, A. P. (1999). Overexpression of protein kinase C betaII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis. The Journal of Cell Biology, 145, 699–711.
Murray, N. R., & Fields, A. P. (1997). Atypical protein kinase C iota protects human leukemia cells against drug-induced apoptosis. The Journal of Biological Chemistry, 272, 27521–27524.
Murriel, C. L., Churchill, E., Inagaki, K., Szweda, L. I., & Mochly-Rosen, D. (2004). Protein kinase C delta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: A mechanism involving bad and the mitochondria. The Journal of Biological Chemistry, 279, 47985–47991.
Mustafi, R., Cerda, S., Chumsangsri, A., Fichera, A., & Bissonnette, M. (2006). Protein kinase-zeta inhibits collagen i-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells. Molecular Cancer Research, 4, 683–694.
Nagata, S. (2006). Apoptosis and autoimmune diseases. IUBMB Life, 58, 358–362.
Neill, G. W., Ghali, L. R., Green, J. L., Ikram, M. S., Philpott, M. P., & Quinn, A. G. (2003). Loss of protein kinase C alpha expression may enhance the tumorigenic potential of gli1 in basal cell carcinoma. Cancer Research, 63, 4692–4697.
Ng, T., Shima, D., Squire, A., Bastiaens, P. I., Gschmeissner, S., Humphries, M. J., et al. (1999). Pkcalpha regulates beta1 integrin-dependent cell motility through association and control of integrin traffic. EMBO Journal, 18, 3909–3923.
Nowak, G. (2002). Protein kinase c-alpha and erk1/2 mediate mitochondrial dysfunction, decreases in active na+ transport, and cisplatin-induced apoptosis in renal cells. The Journal of Biological Chemistry, 277, 43377–43388.
Okhrimenko, H., Lu, W., Xiang, C., Hamburger, N., Kazimirsky, G., & Brodie, C. (2005a). Protein kinase c-epsilon regulates the apoptosis and survival of glioma cells. Cancer Research, 65, 7301–7309.
Okhrimenko, H., Lu, W., Xiang, C., Ju, D., Blumberg, P. M., Gomel, R., et al. (2005b). Roles of tyrosine phosphorylation and cleavage of protein kinase c{delta} in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis. The Journal of Biological Chemistry, 280, 23643–23652.
Oliva, J. L., Caino, M. C., Senderowicz, A. M., & Kazanietz, M. G. (2008). S-phase-specific activation of pkcalpha induces senescence in non-small cell lung cancer cells. The Journal of Biological Chemistry, 283, 5466–5476.
Oster, H., & Leitges, M. (2006). Protein kinase C alpha but not PKC zeta suppresses intestinal tumor formation in ApcMin/+ mice. Cancer Research, 66, 6955–6963.
Parsons, M., & Adams, J. C. (2008). Rac regulates the interaction of fascin with protein kinase C in cell migration. Journal of Cell Science, 121, 2805–2813.
Parsons, M., Keppler, M. D., Kline, A., Messent, A., Humphries, M. J., Gilchrist, R., et al. (2002). Site-directed perturbation of protein kinase c-integrin interaction blocks carcinoma cell chemotaxis. Molecular and Cellular Biology, 22, 5897–5911.
Partovian, C., & Simons, M. (2004). Regulation of protein kinase B/AKT activity and ser473 phosphorylation by protein kinase C alpha in endothelial cells. Cellular Signalling, 16, 951–957.
Patel, R., Win, H., Desai, S., Patel, K., Matthews, J. A., & Acevedo-Duncan, M. (2008). Involvement of PKC-iota in glioma proliferation. Cell Proliferation, 41, 122–135.
Peluso, J. J., Pappalardo, A., & Fernandez, G. (2001). Basic fibroblast growth factor maintains calcium homeostasis and granulosa cell viability by stimulating calcium efflux via a PKCdelta-dependent pathway. Endocrinology, 142, 4203–4211.
Perletti, G. P., Concari, P., Brusaferri, S., Marras, E., Piccinini, F., & Tashjian, A. H. (1998). Protein kinase C epsilon is oncogenic in colon epithelial cells by interaction with the ras signal transduction pathway. Oncogene, 16, 3345–3348.
Pietsch, E., Sykes, S., McMahon, S., & Murphy, M. (2008). The p53 family and programmed cell death. Oncogene, 27, 6507–6521.
Piiper, A., Elez, R., You, S.-J., Kronenberger, B., Loitsch, S., & Roche, S., et al. (2003). Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, yes, and protein kinase c. Signal amplification at the level of raf by activation of protein kinase C epsilon. The Journal of Biological Chemistry, 278, 7065–7072.
Plo, I., Hernandez, H., Kohlhagen, G., Lautier, D., Pommier, Y., & Laurent, G. (2002). Overexpression of the atypical protein kinase C zeta reduces topoisomerase II catalytic activity, cleavable complexes formation, and drug-induced cytotoxicity in monocytic u937 leukemia cells. The Journal of Biological Chemistry, 277, 31407–31415.
Podar, K., Tai, Y. T., Lin, B. K., Narsimhan, R. P., Sattler, M., Kijima, T., et al. (2002). Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation. The Journal of Biological Chemistry, 277, 7875–7881.
Powell, C. T., Brittis, N. J., Stec, D., Hug, H., Heston, W. D., & Fair, W. R. (1996). Persistent membrane translocation of protein kinase C alpha during 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis of lncap human prostate cancer cells. Cell Growth and Differentiation, 7, 419–428.
Prevostel, C., Martin, A., Alvaro, V., Jaffiol, C., & Joubert, D. (1997). Protein kinase C alpha and tumorigenesis of the endocrine gland. Hormone Research, 47, 140–144.
Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., et al. (1997). Somatic frameshift mutations in the bax gene in colon cancers of the microsatellite mutator phenotype. Science, 275, 967–969.
Ranger, A. M., Malynn, B. A., & Korsmeyer, S. J. (2001). Mouse models of cell death. Nature Genetics, 28, 113–118.
Regala, R. P., Thompson, E. A., & Fields, A. P. (2008). Atypical protein kinase C iota expression and aurothiomalate sensitivity in human lung cancer cells. Cancer Research, 68, 5888–5895.
Regala, R. P., Weems, C., Jamieson, L., Khoor, A., Edell, E. S., Lohse, C. M., et al. (2005). Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Research, 65, 8905–8911.
Reno, E. M., Haughian, J. M., Dimitrova, I. K., Jackson, T. A., Shroyer, K. R., & Bradford, A. P. (2008). Analysis of protein kinase C delta (PKCdelta) expression in endometrial tumors. Human Pathology, 39, 21–29.
Reyland, M. E. (2007). In R. Srivastava (Ed.), PKC and apoptosis. Apoptosis, cell signaling, and human disease: Molecular mechanisms. (Vol, 2: 31–55). Totowa, NJ: Humana.
Reyland, M. E., Anderson, S. M., Matassa, A. A., Barzen, K. A., & Quissell, D. O. (1999b). Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells. The Journal of Biological Chemistry, 274, 19115–19123.
Reyland, M., Barzen, K., Anderson, S., Quissell, D., & Matassa, A. (2000). Activation of pkc is sufficient to induce an apoptotic program in salivary gland acinar cells. Cell Death and Differentiation, 7, 1200–1209.
Riedl, S. J., & Shi, Y. (2004). Molecular mechanisms of caspase regulation during apoptosis. Nature Reviews. Molecular Cell Biology, 9, 897–907.
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008). Transcriptional control of human p53-regulated genes. Nature Reviews. Molecular Cell Biology, 9, 402–412.
Riobo, N. A., Haines, G. M., & Emerson, C. P., Jr. (2006). Protein kinase C-{delta} and mitogen-activated protein/extracellular signal-regulated kinase-1 control gli activation in hedgehog signaling. Cancer Research, 66, 839–845.
Rogers, C., Loveday, R., Drew, P., & Greenman, J. (2002). Molecular prognostic indicators in breast cancer. European Journal of Surgical Oncology, 28, 467–478.
Ruvolo, P. P., Deng, X., Carr, B. K., & May, W. S. (1998). A functional role for mitochondrial protein kinase calpha in bcl2 phosphorylation and suppression of apoptosis. The Journal of Biological Chemistry, 273, 25436–25442.
Ryer, E. J., Sakakibara, K., Wang, C., Sarkar, D., Fisher, P. B., Faries, P. L., et al. (2005). Protein kinase C delta induces apoptosis of vascular smooth muscle cells through induction of the tumor suppressor p53 by both p38-dependent and p38-independent mechanisms. The Journal of Biological Chemistry, 280, 35310–35317.
Santiago-Walker, A. E., Fikaris, A. J., Kao, G. D., Brown, E. J., Kazanietz, M. G. & Meinkoth, J. L. (2005). Protein kinase C delta stimulates apoptosis by initiating G1 phase cell cycle progression and S phase arrest. The Journal of Biological Chemistry, 280, 32107–32114.
Sarker, M., Ruiz-Ruiz, C., & López-Rivas, A. (2001). Activation of protein kinase C inhibits trail-induced caspases activation, mitochondrial events and apoptosis in a human leukemic t cell line. Cell Death and Differentiation, 2, 172–181.
Sauma, S., Yan, Z., Ohno, S., & Friedman, E. (1996). Protein kinase C beta 1 and protein kinase C beta 2 activate p57 mitogen-activated protein kinase and block differentiation in colon carcinoma cells. Cell Growth and Differentiation, 7, 587–594.
Schwartz, G. K., Jiang, J., Kelsen, D., & Albino, A. P. (1993). Protein kinase C: A novel target for inhibiting gastric cancer cell invasion. Journal of the National Cancer Institute, 85, 402–407.
Shankar, E., Sivaprasad, U., & Basu, A. (2008). Protein kinase C epsilon confers resistance of mcf-7 cells to trail by akt-dependent activation of hdm2 and downregulation of p53. Oncogene, 27, 3957–3966.
Shanmugam, M., Krett, N. L., Maizels, E. T., Murad, F. M., Rosen, S. T., & Hunzicker-Dunn, M. (2001). A role for protein kinase C delta in the differential sensitivity of MCF-7 and MDA-MB 231 human breast cancer cells to phorbol ester-induced growth arrest and p21waf1/cip1 induction. Cancer Letters, 172, 43–53.
Sharif, T., & Sharif, M. (1999). Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples. International Journal of Oncology, 15, 237–243.
Sheridan, C., & Martin, S. (2008). Commitment in apoptosis: Slightly dead but mostly alive. Trends in Cell Biology, 18, 353–357.
Shibata, M.-A., Liu, M.-L., Knudson, M. C., Shibata, E., Yoshidome, K., Bandey, T., et al. (1999). Haploid loss of bax leads to accelerated mammary tumor development in Cc3(1)/SV40-TAg transgenic mice: Reduction in protective apoptotic response at the preneoplastic stage. EMBO Journal, 18, 2692–2701.
Sitailo, L. A., Tibudan, S. S., & Denning, M. F. (2004). Bax activation and induction of apoptosis in human keratinocytes by the protein kinase C delta catalytic domain. The Journal of Investigative Dermatology, 123, 434–443.
Sitailo, L. A., Tibudan, S. S., & Denning, M. F. (2006). The protein kinase C delta catalytic fragment targets mcl-1 for degradation to trigger apoptosis. The Journal of Biological Chemistry, 281, 29703–29710.
Sivaprasad, U., Shankar, E., & Basu, A. (2006). Downregulation of Bid is associated with PKC epsilon-mediated trail resistance. Cell Death and Differentiation, 14, 851–860.
Silva, D., English, D., Lyons, D., & Lloyd, F.P. Jr. (2002). Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB. Biochemical and Biophysical Research Communications, 11, 552–557.
Slosberg, E. D., Klein, M. G., Yao, Y., Han, E. K., Schieren, I., & Weinstein, I. B. (1999). The alpha isoform of protein kinase c mediates phorbol ester-induced growth inhibition and p21cip1 induction in HC11 mammary epithelial cells. Oncogene 18, 6658–6666.
Smith, L., Chen, L., Reyland, M. E., DeVries, T. A., Talanian, R. V., Omura, S., et al. (2000). Activation of atypical protein kinase C zeta by caspase processing and degradation by the ubiquitin-proteasome system. The Journal of Biological Chemistry, 275, 40620–40627.
Smith, L., Wang, Z., & Smith, J. B. (2003). Caspase processing activates atypical protein kinase C zeta by relieving autoinhibition and destabilizes the protein. Biochemical Journal, 375, 663–671.
Soh, J. W., & Weinstein, I. B. (2003). Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin d1 and related genes. The Journal of Biological Chemistry, 278, 34709–34716.
Steinberg, R., Harari, O. A., Lidington, E. A., Boyle, J. J., Nohadani, M., Samarel, A. M., et al. (2007). A protein kinase C epsilon-anti-apoptotic kinase signaling complex protects human vascular endothelial cells against apoptosis through induction of bcl-2. The Journal of Biological Chemistry, 282, 32288–32297.
Stephanou, A., Scarabelli, T. M., Townsend, P. A., Bell, R., Yellon, D., Knight, R. A., et al. (2002). The carboxy-terminal activation domain of the stat-1 transcription enhances ischemia/reperfusion-induced apoptosis in cardiac myocytes. FASEB Journal, 16, 1841–1843.
Su, T. T., Guo, B., Kawakami, Y., Sommer, K., Chae, K., Humphries, L. A., et al. (2002). PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to bcr signaling. Nature Immunology, 3, 780–786.
Sulston, J. E., & Horvitz, H. R. (1977). Post-embryonic cell lineages of the nematode, caenorhabditis elegans. Developmental Biology, 56, 110–156.
Sun, R., Gao, P., Chen, L., Ma, D., Wang, J., Oppenheim, J. J., et al. (2005). Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Research, 65, 1433–1441.
Sun, X., Wu, F., Datta, R., Kharbanda, S., & Kufe, D. (2000). Interaction between protein kinase C delta and the c-abl tyrosine kinase in the cellular response to oxidative stress. The Journal of Biological Chemistry, 275, 7470–7473.
Svensson, K., Zeidman, R., Troller, U., Schultz, A., & Larsson, C. (2000). Protein kinase C beta1 is implicated in the regulation of neuroblastoma cell growth and proliferation. Cell Growth and Differentiation, 11, 641–648.
Tachado, S., Mayhew, M., Wescott, G., Foreman, T., Goodwin, C., McJilton, M., et al. (2002). Regulation of tumor invasion and metastasis in protein kinase C epsilon-transformed NIH3T3 fibroblasts. Journal of Cellular Biochemistry, 85, 785–797.
Tan, M., Li, P., Sun, M., Yin, G., & Yu, D. (2006). Upregulation and activation of pkc by erbb2 through src promotes breast cancer cell invasion that can be blocked by combined treatment with pkc and src inhibitors. Oncogene, 25, 3286–3295.
Teicher, B. A. (2006). Protein kinase C as a therapeutic target. Clinical Cancer Research, 12, 5336–5345.
Teicher, B. A., Menon, K., Alvarez, E., Galbreath, E., Shih, C., & Faul, M. (2001). Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human T98G glioblastoma multiforme xenografts. Clin Cancer Res, 7: 634–640.
Teicher, B. A., Menon, K., Alvarez, E., Galbreath, E., Shih, C., Faul, M. M. (2001). Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in murine lewis lung carcinoma and human calu-6 non-small-cell lung carcinoma xenografts. Cancer Chemotherapy and Pharmacology, 48, 473–480.
Teicher, B. A., Menon, K., Alvarez, E., Shih, C., & Faul, M. M. (2002). Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human breast cancer and ovarian cancer xenografts. Investigational New Drugs, 20, 241–251.
Thorburn, A. (2004) Death receptor-induced cell killing. Cellular Signalling, 16, 139–144.
Tonetti, D. A., Chisamore, M. J., Grdina, W., Schurz, H., & Jordan, V. C. (2000). Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines. British Journal of Cancer, 83, 782–791.
Toyoda, M., Gotoh, N., Handa, H., & Shibuya, M. (1998). Involvement of map kinase-independent protein kinase C signaling pathway in the EGF-induced p21(waf1/cip1) expression and growth inhibition of A431 cells. Biochemical and Biophysical Research Communications, 250, 430–435.
Tsai, J. H., Hsieh, Y. S., Kuo, S. J., Chen, S. T., Yu, S. Y., Huang, C. Y., et al. (2000). Alteration in the expression of protein kinase C isoforms in human hepatocellular carcinoma. Cancer Letters, 161, 171–175.
Tsujimoto, Y., Cossman, J., Jaffe, E., & Croce, C. M. (1985). Involvement of the bcl-2 gene in human follicular lymphoma. Science, 228, 1440–1443.
Ueda, Y., Hirai, S.-I., Osada, S.-I., Suzuki, A., Mizuno, K., & Ohno, S. (1996). Protein kinase C delta activates the MEK-ERK pathway in a manner independent of ras and dependent on raf. The Journal of Biological Chemistry, 271, 23512–23519.
Utz, P. J., & Anderson, P. (2000). Life and death decisions: Regulation of apoptosis by proteolysis of signaling molecules. Cell Death and Differentiation, 7, 589–602.
Varfolomeev, E. E., Schuchmann, M., Luria, V., Chiannikulchai, N., Beckmann, J. S., Mett, I. L., et al. (1998). Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the tnf receptors, fas/apo1, and dr3 and is lethal prenatally. Immunity, 9, 267–276.
Varga, A., Czifra, G., Tallai, B., (2004). European Urology, 46, 462–465.
Verma, A. K., Wheeler, D. L., Aziz, M. H., & Manoharan, H. (2006). Protein kinase C epsilon and development of squamous cell carcinoma, the nonmelanoma human skin cancer. Molecular Carcinogenesis, 45, 381–388.
Voss, O. H., Kim, S., Wewers, M. D., & Doseff, A. I. (2005). Regulation of monocyte apoptosis by the protein kinase C delta-dependent phosphorylation of caspase-3. The Journal of Biological Chemistry, 280, 17371–17379.
Wakino, S., Kintscher, U., Liu, Z., Kim, S., Yin, F., Ohba, M., et al. (2001). Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21cip1 by modulating the protein kinase C delta pathway in vascular smooth muscle cells. The Journal of Biological Chemistry, 276, 47650–47657.
Wang, S., & Baker, J. (2007) The role of apoptosis in thyroid autoimmunity. Thyroid, 17, 975–979.
Wang, S., & El-Deiry, W. (2003). Trail and apoptosis induction by tnf-family death receptors. Oncogene. 22, 8628–8633.
Wang, G., Silva, J., Krishnamurthy, K., Tran, E., Condie, B. G., & Bieberich, E. (2005). Direct binding to ceramide activates protein kinase C zeta before the formation of a pro-apoptotic complex with par-4 in differentiating stem cells. The Journal of Biological Chemistry, 280, 26415–26424.
Watanabe, T., Ono, Y., Taniyama, Y., Hazama, K., Igarashi, K., Ogita, K., et al. (1992). Cell division arrest induced by phorbol ester in cho cells overexpressing protein kinase C-delta subspecies. Proceedings of the National Academy of Sciences of the United States of America, 89, 10159–10163.
Ways, D. K., Kukoly, C. A., deVente, J., Hooker, J. L., Bryant, W. O., Posekany, K. J., et al. (1995). MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. The Journal of Clinical Investigation, 95, 1906–1915.
Weichert, W., Gekeler, V., Denkert, C., Dietel, M., & Hauptmann, S. (2003). Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis. International Journal of Oncology, 23, 633–639.
Wert, M., & Palfrey, C. (2000). Divergence in the anti-apoptotic signalling pathways used by nerve growth factor and basic fibroblast growth factor (bFGF) in PC12 cells: Rescue by bFGF involves protein kinase C delta. Biochemical Journal, 352, 175–182.
Wetsel, W. C., Khan, W. A., Merchenthaler, I., Rivera, H., Halpern, A. E., Phung, H. M., et al. (1992). Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. The Journal of Cell Biology, 117, 121–133.
Wheeler, D. L., Martin, K. E., Ness, K. J., Li, Y., Dreckschmidt, N. E., Wartman, M., et al. (2004). Protein kinase C epsilon is an endogenous photosensitizer that enhances ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas. Cancer Research, 64, 7756–7765.
Wheeler, D. L., Ness, K. J., Oberley, T. D., & Verma, A. K. (2003). Protein kinase C epsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice. Cancer Research, 63, 6547–6555.
Whelan, R. D., & Parker, P. J. (1998). Loss of protein kinase C function induces an apoptotic response. Oncogene, 16, 1939–1944.
Whitman, S. P., Civoli, F., & Daniel, L. W. (1997). Protein kinase C beta II activation by 1-beta-d-arabinofuranosylcytosine is antagonistic to stimulation of apoptosis and bcl-2alpha down-regulation. The Journal of Biological Chemistry, 272, 23481–23484.
Win, H. Y., & Acevedo-Duncan, M. (2008). Atypical protein kinase C phosphorylates IKKalphabeta in transformed non-malignant and malignant prostate cell survival. Cancer Letters, 270(2), 302–311.
Wolf, B., & Green, D. (1999). Suicidal tendencies: Apoptotic cell death by caspase family proteinases. The Journal of Biological Chemistry, 274, 20049–20052.
Wolff, S., Erster, S., Palacios, G., & Moll, U. M. (2008). P53’s mitochondrial translocation and MOMP action is independent of puma and bax and severely disrupts mitochondrial membrane integrity. Cell Research, 18, 733–744.
Wu, D., Foreman, T. L., Gregory, C. W., McJilton, M. A., Wescott, G. G., Ford, O. H., et al. (2002). Protein kinase C epsilon has the potential to advance the recurrence of human prostate cancer. Cancer Research, 62, 2423–2429.
Wu, T., Hsieh, Y.-H., Hsieh, Y.-S., & Liu, J. (2008). Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma. Journal of Cellular Biochemistry, 103, 9–20.
Wyllie, A. H., Kerr, J. F., & Currie, A. R. (1972). Cellular events in the adrenal cortex following ACTH deprivation. Journal of Pathology, 106, Pix.
Wyllie, A. H., Kerr, J. F., & Currie, A. R. (1973). Cell death in the normal neonatal rat adrenal cortex. Journal of Pathology, 111, 255–261.
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., et al. (1996). Characterization of vascular endothelial growth factor’s effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. The Journal of Clinical Investigation, 98, 2018–2026.
Xiao, L., Caino, M. C., von Burstin, V. A., Oliva, J. L., & Kazanietz, M. G. (2008). Phorbol ester-induced apoptosis and senescence in cancer cell models. Methods in Enzymology, 446, 123–139.
Xin, M., Gao, F., May, W. S., Flagg, T., & Deng, X. (2007). Protein kinase czeta abrogates the proapoptotic function of bax through phosphorylation. The Journal of Biological Chemistry, 282, 21268–21277.
Yamaguchi, T., Miki, Y., & Yoshida, K. (2007). Protein kinase C delta activates IkappaB-kinase alpha to induce the p53 tumor suppressor in response to oxidative stress. Cellular Signalling, 19, 2088–2097.
Yin, L., Bennani-Baiti, N., & Powell, C. T. (2005). Phorbol ester-induced apoptosis of C4–2 cells requires both a unique and a redundant protein kinase C signaling pathway. Molecular and Cellular Biology, 280, 5533–5541.
Yin, J. Q., Gao, J., Shao, R., Tian, W. N., Wang, J., & Wan, Y. (2003). SiRNA agents inhibit oncogene expression and attenuate human tumor cell growth. Journal of Experimental Therapeutics & Oncology, 3, 194–204.
Yip, K., & Reed, J. (2008). Bcl-2 family proteins and cancer. Oncogene, 27, 6398–6406.
Yonekawa, H., & Akita, Y. (2008). Protein kinase C epsilon: The mitochondria-mediated signaling pathway. FEBS Journal, 275, 4005–4013.
Yoshida, K. (2007). PKC delta signaling: Mechanisms of DNA damage response and apoptosis. Cellular Signalling, 19, 892–901.
Yoshida, K., Liu, H., & Miki, Y. (2006). Protein kinase C delta regulates ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. The Journal of Biological Chemistry, 281, 5734–5740.
Yoshida, K., Miki, Y., & Kufe, D. (2002). Activation of SAPK/JNK signaling by protein kinase C delta in response to DNA damage. The Journal of Biological Chemistry, 277, 48372–48378.
Yoshida, K., Wang, H., Miki, Y. & Kufe, D. (2003). Protein kinase C delta is responsible for constitutive and DNA damage induced phosphorylation of rad9. EMBO Journal, 22, 1431–1441.
Yoshiji, H., Kuriyama, S., Ways, D. K., Yoshii, J., Miyamoto, Y., Kawata, M., et al. (1999). Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis. Cancer Research, 59, 4413–4418.
Youle, R. J., & Strasser, A. (2008). The bcl-2 protein family: Opposing activities that mediate cell death. Nature Review. Molecular Cell Biology, 9, 47–59.
Yuan, Z.-M., Utsugisawa, T., Ishiko, T., Nakada, S., Huang, Y., Kharbanda, S., et al. (1998). Activation of protein kinase C delta by the c-abl tyrosine kinase in response to ionizing radiation. Oncogene, 16, 1643–1648.
Zang, Q., Lu, Z., Curto, M., Barile, N., Shalloway, D., & Foster, D. A. (1997). Association between v-src and protein kinase C delta in v-src-transformed fibroblasts. The Journal of Biological Chemistry, 272, 13275–13280.
Zhang, J., Anastasiadis, P. Z., Liu, Y., Thompson, E. A., & Fields, A. P. (2004). Protein kinase C (PKC) betaII induces cell invasion through a ras/MEK-, PKC iota/rac 1-dependent signaling pathway. The Journal of Biological Chemistry, 279, 22118–22123.
Zheng, T. S., & Flavell, R. A. (2000). Divinations and suprises: Genetic analysis of caspase function in mice. Experimental Cell Research, 256, 67–73.
Zhu, Y., Dong, Q., Tan, B. J., Lim, W. G., Zhou, S., & Duan, W. (2005). The PKC alpha-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signals. Cancer Research, 65, 4520–4524.
Zhuang S., Demirs, J. T., & Kochevar, I. E. (2001). Protein kinase C inhibits singlet oxygen-induced apoptosis by decreasing caspase-8 activation. Oncogene, 20, 6764–6776.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Reyland, M.E., Bradford, A.P. (2010). PKC and the Control of Apoptosis. In: Kazanietz, M. (eds) Protein Kinase C in Cancer Signaling and Therapy. Current Cancer Research. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-543-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-60761-543-9_9
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-542-2
Online ISBN: 978-1-60761-543-9
eBook Packages: MedicineMedicine (R0)